Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Yunnan Baiyao Group Co., (000538 CH)
Watchlist
65
Analysis
Health Care
•
China
Yunnan Baiyao Group Co., Ltd. manufactures and markets traditional Chinese medicines. The Company also operates in pharmaceutical wholesale and retail trading, empty capsules manufacturing, and hotel operation.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cross Asset Strategy
•
19 Mar 2019 08:41
The China A-Share Revolution
Copley Fund Research analyse the holdings of long-only Global Emerging Market equity funds. All of the Funds in this analysis are actively managed...
Steven Holden
Follow
1.2k Views
Share
bearish
•
Thematic (Sector/Industry)
•
09 Oct 2017 16:15
Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down
We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...
Bucephalus Research Partnership
606 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Feb 2017 09:14
Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?
While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...
Euromonitor International Ltd.
3.3k Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 13:50
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
Dion Stéfan Büchner M.D., FCAP
643 Views
Share
bullish
•
Thematic (Sector/Industry)
•
31 Dec 2016 20:34
•
Syndicated
Pakistan Market Outlook 2017
Pakistan market is expected to continue its uptrend in 2017 given tangible gains from China Pakistan Economic Corridor (CPEC) projects and rising...
Topline Securities
Follow
572 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x